Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cox IA"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-4 z 4
    Tytuł:
    The relative contribution of co-morbidities to health-related quality of life of people with idiopathic pulmonary fibrosis using the Assessment of Quality of Life-8-Dimension multi-attribute utility instrument.
    Autorzy:
    Zheng Q; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.; Department of Anaesthesiology (High-Tech Branch), the First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.
    Cox IA; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.
    de Graaff B; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.
    Campbell JA; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.
    Corte TJ; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.; Central Clinical School, The University of Sydney, Camperdown, Australia.; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
    Glaspole I; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.; Department of Allergy and Respiratory Medicine, The Alfred Hospital, Melbourne, Australia.; Faculty of Medicine, Monash University, Melbourne, Australia.
    Navaratnam V; Australian Idiopathic Pulmonary Fibrosis Registry, Lung Foundation of Australia, Camperdown, NSW, Australia.; Queensland Lung Transplant Service, The Prince Charles Hospital, Brisbane, Australia.
    Hopkins P; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.; Queensland Centre for Pulmonary Transplantation and Vascular Disease, The Prince Charles Hospital, Chermside, Australia.; Faculty of Medicine, University of Queensland, Queensland, Australia.
    Zappala C; Department of Thoracic Medicine, Royal Brisbane & Women's Hospital, Brisbane, QLD, Australia.
    Ahmad H; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.; Australian Government Department of Health and Aged Care, Tasmania (TAS) Office, Australia.
    Zhao T; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.
    Macansh S; Australian Idiopathic Pulmonary Fibrosis Registry, Lung Foundation of Australia, Camperdown, NSW, Australia.
    Walters EH; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia.; School of Medicine, University of Tasmania, Hobart, TAS, Australia.
    Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, 7001, Australia. .; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, NSW, Australia. .
    Pokaż więcej
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Jun; Vol. 32 (6), pp. 1609-1619. Date of Electronic Publication: 2022 Dec 26.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Quality of Life*/psychology
    Idiopathic Pulmonary Fibrosis*
    Humans ; Surveys and Questionnaires ; Australia ; Morbidity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Mapping EQ5D utilities from forced vital capacity and diffusing capacity in fibrotic interstitial lung disease.
    Autorzy:
    Wong AW; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
    Sun H; Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.
    Cox IA; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
    Fisher JH; Department of Medicine, University of Toronto, Toronto, ON, Canada.
    Khalil N; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
    Johannson KA; Department of Medicine, University of Calgary, Calgary, AB, Canada.
    Marcoux V; Department of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
    Assayag D; Department of Medicine, McGill University, Montreal, Quebec, Canada.
    Manganas H; Département de Médecine, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada.
    Kolb M; Department of Medicine, Firestone Institute for Respiratory Health, McMaster University, Hamilton, ON, Canada.
    Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
    de Graaff B; Menzies Institute for Medical Research, University of Tasmania, Hobart, Tasmania, Australia.
    Walters EH; School of Medicine, University of Tasmania, Hobart, Tasmania, Australia.
    Hopkins P; Lung Transplant Unit, The Prince Charles Hospital, Brisbane, Australia.
    Zappala C; Dept of Thoracic Medicine, Royal Brisbane and Women's Hospital, Brisbane, Australia.
    Goh NS; Dept of Respiratory and Sleep Medicine, Austin Hospital, Heidelberg, Australia.
    Moodley Y; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
    Navaratnam V; Lung Transplant Unit, The Prince Charles Hospital, Brisbane, Australia.
    Corte TJ; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Sydney, NSW, Australia.; Centre of Research Excellence for Pulmonary Fibrosis, University of Sydney, Sydney, NSW, Australia.
    Ryerson CJ; Department of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.; Centre for Heart Lung Innovation, St. Paul's Hospital, Vancouver, British Columbia, Canada.
    Zhang W; Centre for Health Evaluation and Outcome Sciences, Vancouver, British Columbia, Canada.; School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2023 Mar 31; Vol. 18 (3), pp. e0283110. Date of Electronic Publication: 2023 Mar 31 (Print Publication: 2023).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Lung Diseases, Interstitial*/drug therapy
    Idiopathic Pulmonary Fibrosis*/drug therapy
    Humans ; Australia ; Canada ; Lung ; Vital Capacity
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Assessment of health-related quality of life in Australian patients with idiopathic pulmonary fibrosis: a comparison of the EQ-5D-5L and the AQoL-8D.
    Autorzy:
    Cox IA; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.
    Campbell J; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.
    de Graaff B; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.
    Otahal P; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.
    Corte TJ; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.; Central Clinical School, The University of Sydney, Camperdown, Australia.; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, Australia.
    Moodley Y; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.; Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.; Institute of Respiratory Health, The University of Western Australia, Perth, Australia.; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
    Hopkins P; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.; Queensland Centre for Pulmonary Transplantation and Vascular Disease, The Prince Charles Hospital, Chermside, Australia.; Faculty of Medicine, University of Queensland, Brisbane, QLD, Australia.
    Macansh S; Australian Idiopathic Pulmonary Fibrosis Registry, Lung Foundation of Australia, New South Wales, Australia.
    Walters EH; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia.
    Palmer AJ; Menzies Institute for Medical Research, University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia. .; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Melbourne, Australia. .
    Pokaż więcej
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2023 Feb; Vol. 32 (2), pp. 473-493. Date of Electronic Publication: 2022 Aug 04.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Quality of Life*/psychology
    Humans ; Australia ; Surveys and Questionnaires ; Psychometrics/methods
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The impact of idiopathic pulmonary fibrosis on health state utility values: evidence from Australia.
    Autorzy:
    Cox IA; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.
    de Graaff B; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.
    Ahmed H; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.
    Campbell J; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.
    Otahal P; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.
    Corte TJ; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.; Central Clinical School, The University of Sydney, Camperdown, Australia.; Department of Respiratory and Sleep Medicine, Royal Prince Alfred Hospital, Camperdown, Australia.
    Glaspole I; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.; Alfred Hospital, Melbourne, Australia.; Monash University, Melbourne, Australia.
    Moodley Y; Faculty of Health and Medical Sciences, The University of Western Australia, Perth, Australia.; Institute of Respiratory Health, The University of Western Australia, Perth, Australia.; Department of Respiratory Medicine, Fiona Stanley Hospital, Murdoch, Australia.
    Goh N; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.; Alfred Hospital, Melbourne, Australia.
    Macansh S; Australian Idiopathic Pulmonary Fibrosis Registry, Lung Foundation of Australia, Camperdown, Australia.
    Walters EH; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia.; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia.
    Palmer AJ; Menzies Institute for Medical Research, The University of Tasmania, 17 Liverpool Street, Hobart, TAS, Australia. .; NHMRC Centre of Research Excellence for Pulmonary Fibrosis, Camperdown, Australia. .; Centre for Health Policy, School of Population and Global Health, The University of Melbourne, Melbourne, Australia. .
    Pokaż więcej
    Źródło:
    Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation [Qual Life Res] 2021 Sep; Vol. 30 (9), pp. 2615-2632. Date of Electronic Publication: 2021 May 17.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Idiopathic Pulmonary Fibrosis*/epidemiology
    Quality of Life*/psychology
    Australia/epidemiology ; Humans ; Registries ; Severity of Illness Index ; Surveys and Questionnaires
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-4 z 4

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies